Last year, PEG-Intron (Schering-Plough) received FDA approval
after studies indicated that the drug, when given in combination with
ribavirin, suppressed hepatitis C in 52% of subjects.
According to Henry Bodenheimer, chief of the division of digestive diseases
at Beth Israel Medical Center, the findings also showed that optimum results
could be attained by adapting the treatment regimen to the type of hepatitis
C in the subject's bloodstream.
Luke's Medical Center in Chicago, said: "The data is very important
because we now know that for certain patients, we can use a lower dose
of therapy and cut the treatment duration by half without sacrificing
efficacy.
All were severely immunosuppressed, six (86%) had poorly controlled HIV
replication despite combination antiretroviral therapy, and five (71%)
had HIV-associated dementia.
edu_phc
The Program coordinates the health care of people living with
HCV, and people who may be at increased risk of HCV infection.
Each education session is self-contained, so it is possible to only attend
those of particular interest to you.
However, you are encouraged to attend them all as they build to give a
complete overview of Hepatitis C care & prevention issues.
This education program has been submitted to RACGP for point allocation
in the 5 pph Professional Development category of the QA and CE program
To be eligible for the 5pph CME points you will need to complete a comprehensive
pre and post test questionnaire.
CI_6230_8A
http://www.uscg.mil/ccs/cit/cim/directives/CI/CI_6230_8A.pdf To establish policy and guidelines regarding immunization and
prophylaxis against Hepatitis A virus.
Hepatitis A infection, a disease of the liver, is acquired primarily via
the fecal-oral route by either person-to-person contact or ingestion of
contaminated food or water.
Risk of infection with Hepatitis A virus (HAV) is highest in developing
countries where environmental sanitation and personal hygiene are poor.
Since transmission of HAV occurs through direct or indirect contact with
fecal matter (i.e., via the fecal-oral route), the risk of infection can
be greatly reduced through standard public health measures.
Long-term prevention of this infection can be achieved through immunization
with a two-dose series of Hepatitis A vaccine.
casereport
Department of Gastroenterology, Seth G S Medical College and
K E M Hospital, Mumbai 400 012 Familial clustering of hepatitis B virus
infection has been reported infrequently.
We report a family of 27 members, where 13 members were HBsAg-positive.
Familial clustering of hepatitis B virus (HBV) infection has been reported.1
The mode of transmission of the infection in the family may be vertical
or horizontal.
Familial transmission of HBV infection is classified into six types: generational,
horizontal, recessive, intra- and extra-familial, nonfamilial and undetermined.2
If the subtype in children is similar to that in the mother, it suggests
maternal transmission; on the other hand, if the subtype is similar to
the locally dominant one, it could be horizontal transmission.
Vaccination against HBV infection is important in such families.
PNAS96a
Total viral release into the periphery is '1011 virus particles
per day.
Although we have no direct measurement of the infected cell mass, we can
estimate the turnover rate of these cells in two ways: (i) by comparing
the rate of viral production before and after therapy or (ii) from the
decline of hepatitis B antigen during treatment.
During drug treatment the cccDNA copy number per infected cell may decline,
which could lead to less viral and HBeAg production independent of death
of infected cells.
In a chronic HBV infection, between 5% and 40% of all hepatocytes can
be infected and produce virus (18).
eNews_02_10
Email: khumbaugh@louisville.edu Hepatitis B infection carries
a high burden of disease in terms of morbidity and early mortality, both
worldwide and nationwide.
In areas where hepatitis B is endemic, perinatal transmission from an
infected mother to her child is the primary means of infection.
Welcome to this issue of the Kentucky Women's Health eNewsletter, a collaborative
educational effort to communicate advances in women's, maternal, and child
health to all those involved in it across the Commonwealth.
He and his coworkers there compared cervical ripening using the prostaglandin
agent misoprostol to low-dose oxytocin infusion in a well-designed trial,
and found that the therapies had similar efficacy.
2000-summer
Despite the fact that the number of cases of hepatitis A (HA)
reported to Orange County Public Health remains at relatively low levels,
several months ago HA was making headlines in the County.
Diagnosis of acute HA requires laboratory documentation of HA IgM antibody.1
Unless the HA IgM antibody test is specifically requested, separately
or as part of an acute hepatitis panel, laboratories will usually only
do the "total" HA antibody test,2 which is positive when either
HA IgG antibodies or HA IgM antibodies are present.
Orange Health Care Agency, Birth and Death Registration Unit began coding
the underlying cause of death on Death Certificates using the International
Statistical Classification of Diseases and Related Health Problems, Tenth
Revision (ICD-10).
Hepatitis Cholangitis RUQ
Many patients with HepB-associated HCC do not have cirrhosis,
while nearly all patients with HepC-associated HCC do Hepatitis C RNA
is the first biomarker to become positive in acute HCV.
Ultrasound has a sensitivity of 95% for gallstones, better than CT while
both have a sensitivity of 75% for choledocholithiasis in the presence
of dilated ducts.
HCV Ab's are usually present by the time symptoms are present but may
be delayed for quite some time in patients with subclinical infection
A meta-analysis of four randomized trials involving 141 patients with
acute transfusion-acquired HCV found that patients treated with interferon
monotherapy had a greater likelihood of having an end-of-treatment virologic
response (42 versus 4 percent) and a sustained virologic response (32
versus 4 percent).
hepatit
http://www.vmedcenter.org/HBW/pdf/hepatit.pdf Hepatitis is an infection of the liver, caused by a viral infection,
that causes inflammation of the liver and can reduce it's ability to perform
normal blood cleansing functions.
This virus is usually spread from person to person as a result of poor
hygiene habits (especially when handling food.) It can also be contracted
from drinking contaminated water or eating food that has been processed
with sewage contaminated water.
People with this virus may show no symptoms.
People in the medical field who are routinely exposed to blood or people
who have received blood transmission are susceptible to this type.
enri209
http://www.ca.uky.edu/enri/pubs/enri209.pdf other foods that have not been washed.
Viruses are a threat because medicine and drugs don't work well against
them.
It is unknown how many viruses can be in our water and it still be safe.
Hepatitis virus can be in your blood and stool for 2-3 weeks before symptoms
develop and 2-3 weeks afterward.
Wash fruits and vegetables well before eating them.
If a family member gets Hepatitis A, clean toilets and floors with a disinfectant.
Flush contaminated stool directly down the toilet and wash hands afterward.
Educational Programs of the Kentucky Cooperative Extension Service serve
all people regardless of race, color, age, , religion, disability.
idsehep
he treatment of viral hepatitis has evolved over the past 10
years as newer pharTmacologic agents have become available.
Hospitalization is warranted for intractable symptoms of anorexia or vomiting,
severe impairment of liver synthetic function, or development of encephalopathy.
Most patients with acute hepatitis C are asymptomatic and anicteric; they
often do not present to their physicians or healthcare providers.
Complete response to interferon is characterized by an ALT flare with
sequential clearance of HBV DNA and eAg.
Between 20 and 30 years of hepatitis C infection are required for the
development of cirrhosis and hepatoma.
Long-term outcome of hepatitis B e antigen--positive patients with compensated
cirrhosis treated with interferon alfa.Hepatology.1997;26:1338-1342.
roleofaclinicalpharmacist
This report will describe the functions of a clinical pharmacist
involved in a multidisciplinary hepatitis C clinic in a Veterans Administration
Medical Center.
A pharmacist was assigned to participate in the clinic to assist in identifying
patients most likely to benefit from medical intervention, to improve
patient compliance, and to monitor patient outcomes.
The team pharmacist participates in developing patient specific care plans,
provides intensive medication counseling, and schedules follow up care.
These patients are stable on treatment and evaluated by the pharmacist
for response to treatment, compliance with drug therapy, and management
of drug therapy side effects.
The clinic pharmacist is a valued member of the hepatitis C team and plays
an integral role in the care and management of hepatitis C patients.
